STABL Share Price Performance
SEK 0.21
-0.26 (-54.89%)
Price SEK 0.21
Share Pricen/a
Stayble Therapeutics AB (publ) Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
STABL Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Stayble Therapeutics AB (publ) Key Details
About STABL
- Founded
- 2015
- Employees
- 2
- CEO
- WebsiteView website
Stayble Therapeutics AB (publ) develops injectable treatment for chronic pain triggered by disc degeneration. The company develops STA363, an injection into the disc that targets chronic low back and leg pain. Stayble Therapeutics AB (publ) was incorporated in 2015 and is based in Gothenburg, Sweden.
